author-photo

Alain Thibault

University of Virginia

43

Papers

2158

Citations

Citation Trend

Filter By

Papers (26) Sort By

Journal Conference Others

The NHance ® Mutation-Equipped Anti-MET Antibody ARGX-111 Displays Increased Tissue Penetration and Anti-Tumor Activity in Advanced Cancer Patients.

2021 Biomedicines
Show All
- Source
- Cite
- Save
Citations (0)
LBA29Immune activation with a novel immune switch anti-macrophage antibody (anti-Clever-1 mAb; FP-1305) in phase I/II first-in-human MATINS trial in patients with advanced solid tumours

2019 Annals of Oncology
Show All
- Source
- Cite
- Save
Citations (4)
Phase I dose-escalation study of the anti-CD70 antibody ARGX-110 in advanced malignancies

2017 Clinical Cancer Research
Show All
- Source
- Cite
- Save
Citations (23)
Abstract P2-05-17: ARGX-111 depletes MET-expressing circulating tumor cells via enhanced ADCC, resulting in inhibition of metastasis

2016 Cancer Research
Show All
- Source
- Cite
- Save
Citations (0)
Abstract 3563: Unlocking the potential of CD70 as a therapeutic target in non-small cell lung cancer

2015 Cancer Research
Show All
- Source
- Cite
- Save
Citations (0)
P7.02The clinical potential of ARGX-111, an afucosylated anti-MET antibody, in hematological malignancies and suppression of metastasis

2015 Annals of Oncology
Show All
- Source
- Cite
- Save
Citations (3)
A phase I, first-in-human study of argx-111, a monoclonal antibody targeting c-met in patients with solid tumors.

2015 Journal of Clinical Oncology
Show All
- Source
- Cite
- Save
Citations (10)
Dossier 18. Consulting en people management

2014
- Alain Thibault
Show All
- Source
- Cite
- Save
Citations (0)
ARGX-110, a highly potent antibody targeting CD70, eliminates tumors via both enhanced ADCC and immune checkpoint blockade

2014 mAbs
Show All
- Source
- Cite
- Save
Citations (52)
Abstract 5470: Pre-clinical characterization of ARGX-110: A neutralizing, humanized monoclonal antibody to the human CD70 antigen with enhanced ADCC properties.

2013 Cancer Research
Show All
- Source
- Cite
- Save
Citations (0)